SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oncothyreon
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Curtis who started this subject5/24/2001 12:58:51 PM
From: keokalani'nui   of 2344
 
I didn't realize LIL-2 failed to improve BLP-25. BLP-25 trial is moving super slow, and the original T-cell results were not as robust as first hoped. The colorectal results though positive, are a really small benefit.

Guys, I think its all up to Theratope now. There will likely not be an early survival showing, so you're looking at a long time for good news. I'm scaling back my small position. Good luck.

Wilder
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News